Omni Bio Pharmaceutical Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$1.63 M |
Shares Outstanding |
50.06 M |
Public Float |
- |
Address |
181 West Boardwalk Drive Fort Collins Colorado 80525 United States |
Employees | - |
Website | http://www.omnibiopharma.com |
Updated | 07/08/2019 |
Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company, which engaes in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naurally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO. |